Back

Hemoglobin/creatinine ratio as long- term prognostic marker in acute coronary syndromes: a praise registry study.

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Risk factors, risk scores, and outcomes after acute coronary syndromes Biomarkers ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Luigi Spadafora

Sapienza University of Rome, Latina (Italy)

8 More presentations in this session

Presentation thumbnail
Unraveling the paradox: the impact of one or more traditional risk factors on short-term mortality following acute coronary syndromes.
Doctor M. Bergami (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
Comparison of GRACE and TIMI risk scores in the prediction of in hospital outcome among NSTEMI patients: a single centre study
Doctor M. CHOWDHURY (Dhaka, BD)
Abstract Slides Video
Presentation thumbnail
Association of polymorphism of apolipoprotein e gene with acute myocardial infarction and its short term clinical outcome
Professor M. Chaliha (Assam, IN)
Abstract Slides Video
Presentation thumbnail
Nomogram-based prediction of MACE in older adults with STEMI
Doctor A. Hernandez (Storrs, US)
Abstract Slides Video
Presentation thumbnail
Baseline shock index-creatinine clearance score and long-term mortality after ACS. Results from 24 years of follow-up of the ABC study on heart disease.
Doctor G. Berton (Conegliano, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Risk factors, risk scores, and outcomes after acute coronary syndromes

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Hemoglobin/creatinine ratio predicts mortality in hospitalized patients for acute heart failure with reduced ejection fraction
thumbnail
Congress Presentation
Hemoglobin and long-term risk of death in patients with acute myocardial infarction
thumbnail
Congress Presentation
Single spot albumin to creatinine ratio as an independent predictor of 12 years follow-up mortality in acute coronary syndromes without ST-segment elevation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources